ResearchGate is a network dedicated to science and research. Connect, collaborate and discover scientific publications, jobs and conferences. All for free Ph.D - School of Chemistry, University of Hyderabad () blogger.com - Department of Chemistry, Kanchi Mammunivar Centre for PG Studies, Pondicherry () blogger.com - Department of Chemistry, St Joseph College of Arts & Science, Cuddalore () Post-doctoral Research Experience: 1) Institut fur Pharmazie und Biochemie, Johannes Gutenberg Aug 29, · In , at the same University, he earned a PhD in Pharmaceutical Sciences. His PhD thesis work received the national award as the best PhD thesis in Medicinal Chemistry organized by Società Chimica Italiana (SCI) and the international Paul Ehrich MedChem Euro-PhD Network certificate for the excellence. Dr
Welcome to Repository@USM - USM Research and Publication
Start of sessions. Programme Indicated times are in CEST timezone. Sunday August 29, EFMC-ISMC Opening Morning Session. Karl-Heinz ALTMANN ETH ZÜRICH, Zürich, Switzerland. Opening Lecture Creating the Next Generation of Therapeutics - Medicinal Chemistry Unleashed PL Dr Karin BRINER NOVARTIS, Cambridge, phd thesis protease purification, United States Dr Karin BRINER ×.
Karin Briner Vice President, Global Discovery Chemistry, Novartis Karin leads Global Discovery Chemistry at Novartis and has phd thesis protease purification for discovery chemistry research globally across all disease areas, focusing with her team on delivering a continuous stream of first-in-class and differentiated molecules to the clinic. Throughout her career, Karin has stayed close to the scientific experiment, contributing as inventor and maintaining her own chemistry laboratory still when she had responsibilities as Executive Director.
She serves as member of several advisory boards to support initiatives in the public and scientific community and has regularly served as a symposium organizer and session chair for chemistry and medicinal chemistry conferences. She also participated in starting the Innovative Medicines Initiative as a member of efpia’s Research Directors Group in Before joining Novartis inKarin was at Eli Lilly phd thesis protease purification Company, where she was Vice President of Translational Sciences and Technologies with responsibilities for biomarker discovery research, structural biology, and in vitro screening.
Karin had started her industry career at Eli Lilly in Indianapolis as Senior Organic Chemist in Infectious Diseases. She led projects in Neuroscience and Endocrine Research, was Executive Director of Lead Optimization Chemistry, then Managing Director of the Lilly Research Centre in the UK and a member of the board of Eli Lilly and Co. before returning to Indianapolis to lead Translational Sciences and Technologies. Karin obtained her BSc in chemistry and biochemistry and her PhD in organic chemistry from the University of Zurich, working with Professor Vasella.
She did NSF and NIH postdoctoral studies with Professor Bill Roush at Indiana University. Phd thesis protease purification Yves P. TH NAUTA STICHTING, The Netherlands. The Nauta Pharmacochemistry Award for Medicinal Chemistry and Chemical Biology Award Lecture Partial Agonism in the Picture AL IJZERMAN ×.
IJzerman, professor of medicinal chemistry at the Leiden Academic Centre for Drug Research, Leiden University, phd thesis protease purification, the Netherlands. Ad IJzerman is an expert on G protein-coupled receptors GPCRsan important class of drug targets. Over the years he has blended his medicinal chemistry background with computational and pharmacological approaches to unravel novel concepts in GPCR drug discovery.
Gradually he developed the notion that GPCRs are "allosteric machines", which are activated and inhibited in many different ways. Principles studied by him such as intrinsic efficacy, insurmountable antagonism and residence time scratch the surface of what is known about this protein superfamily.
His contributions to collaborative efforts in phd thesis protease purification structural biology of GPCRs, long thought out of reach, elucidated and visualized among phd thesis protease purification i the unexpected binding orientation of an antagonist, ii the sodium ion binding site on many GPCRs, phd thesis protease purification, and iii the textbook-changing presence of two antagonists at the same time.
Ad was trained as a pharmacist at Utrecht University, and obtained his PhD degree in medicinal chemistry at the Vrije Universiteit Amsterdam under the supervision of Henk Timmerman.
Thereafter he moved to Leiden University, where he has been a professor since EFMC-ISMC Opening Afternoon Session. Malin Lemurell is the Head of Head of Medicinal Chemistry in Cardiovascular, Renal and Metabolism at AstraZeneca Gothenburg, Sweden.
Malin received her PhD at the Gothenburg University in in organic chemistry. After post-doctoral studies on metal catalyzed asymmetric oxidation at The Scripps Research Institute in California with Prof. Barry Sharpless, she joined AstraZeneca as a scientist and has subsequently held various leadership roles.
Lemurell is an author of multiple publications and patents, including patents related to eg. Odevixibat and AZD Phase II. Her current interests include drug design across small molecules and New Modalities, phd thesis protease purification, targeted drug delivery, drugging RNA structure using small molecules and to develop drug hunters of the future.
The Prous Institute - Overton and Meyer Award for New technologies in Drug Discovery Award Lecture De Novo Drug Design with Machine Intelligence AL Gisbert SCHNEIDER ETH ZÜRICH, Zürich, Switzerland. Monday August 30, Plenary Session. Jean-Paul Clozel is a cardiologist educated in France, with further phd thesis protease purification in pharmacology and physiology at the University of Montreal, Canada, and the University of California, San Francisco, phd thesis protease purification.
After eleven years as a phd thesis protease purification, he decided to move to applied research. During his 12 years at F. Hoffmann-La Roche Ltd, he was responsible for the selection of the first T-channel blocker. He also participated in the characterization of renin inhibitors as well as several endothelin receptor antagonists such as bosentan and clazosentan.
Overall, the group he was heading discovered seven compounds that entered clinical trials. During his year-career in cardiology, he has published widely in peer-reviewed medical and scientific journals. At the same time, his passion has remained unchanged: being involved as closely as possible in bringing innovative medicine to "his" patients. He has developed various, novel experimental models allowing the differentiation of these drugs, work honored with the Hoffmann-La Roche Research Prize.
In he was nominated professor at the Collège de France in Paris, France Chair of Technical Phd thesis protease purification. At the end ofphd thesis protease purification, Jean-Paul founded Actelion, together with his wife, Martine, and work colleagues and friends Walter Fischli, Thomas Widmann and André J.
First mainly focusing on Research and Development, he became CEO of the company to bring Actelion to the public in April Idorsia, a new biopharmaceutical phd thesis protease purification, is specialized in the discovery and development of small molecules to provide innovative therapeutic options. Jean-Paul retains his role as CEO. Session 1 'Chemical Biology' Molecular Imaging Tools for Chemical Biology.
Session 2 'Technologies' Novel Strategies and Methods for Drug Discovery and Development CPA Session. Session 3 'Drug Discovery Projects' Chemical Tools and Drug Discovery for Neuroinflammation EuChemS Session. Valle Palomo is a Junior Leader researcher at the Centre for Biological Research CSIC in Madrid. She studied Chemistry and obtained her PhD from the Autónoma University of Madrid in in Organic Chemistry. She performed a postdoctoral research stay at The Scripps Research Institute with Prof.
Dawson from to In she started her own group focused on Medicinal Chemistry, phd thesis protease purification, Chemical Biology and Nanotechnology. Her lab focuses on the understanding of neurodegenerative diseases, especially amyotrophic lateral sclerosis, and in the discovery of novel agents for its treatment. Gonçalo BERNARDES ×, phd thesis protease purification. After completing his D.
in at the University of Oxford, U. He started his independent research career in at the University of Cambridge as a Royal Society University Research Fellow. In he was appointed University Lecturer Tenured and recently has been promoted to Reader Associate Professor. Gonçalo is the recipient of two European Research Council grants; a starting grant and a proof-of-concept grant, and was awarded the Harrison–Meldola Memorial Prize in and the MedChemComm Emerging Investigator Lectureship inboth from the Royal Society of Chemistry.
His research group interests focus on the use of chemistry principles to tackle challenging biological problems for understanding and phd thesis protease purification cancer, phd thesis protease purification.
Pablo RIVERA FUENTES EPF LAUSANNE, Lausanne, Switzerland Prof. Pablo RIVERA FUENTES ×. Pablo Rivera-Fuentes is assistant professor of chemical biology at EPF Lausanne.
His laboratory works on the development of chemical and biological probes to visualize and control biological problems with sub-cellular precision. Prior to his appointment at EPFL, he was an independent group leader at ETH Zurich – His training includes a PhD in chemistry from ETH Zurichas well as postdoctoral training at MIT and the University of Oxford – Sensing Enzymatic Activity with Quantum Dots in Patient-Derived Neurodegenerative Disease Models LE Pattern-generating Fluorescent Molecular Probes for Chemical Biology LE Dr Leila MOTIEI WEIZMANN INSTITUTE OF SCIENCE, Rehovot, Israel Dr Leila MOTIEI ×.
Leila Motiei obtained her M. in Chemistry from Bar-Ilan University, Israel in She then moved to the Scripps Research Institute in La Jolla, California where she worked with Prof. Reza Ghadiri as a research assistant – Her research involved the study of antibacterial cyclic D,L-α-glycopeptides.
Inshe returned to Israel to conduct her PhD studies at the Weizmann Institute of Science under supervision of Prof. Milko E. van der Boom studying the exponential formation of molecular-based assemblies. Sinceshe has been an associate staff scientist in the group of Prof. David Margulies at the Weizmann Institute of Science. Her research interests focus on developing pattern-generating fluorescent molecular probes, turn-on fluorescent probes, targeted protein surface receptors, and biomimetics of signaling proteins.
Along the Allostery Stream: Recent Advances in Computational Methods for Allosteric Drug Discovery LE Jian ZHANG ×. Jian Zhang, Director of Medicinal Bioformatics Center in Shanghai Jiaotong Unversity School of Medicine. In the last ten years, he has made a series of cutting-edge breakthroughs in drug discovery, which were achieved through the development of allosteric drug design methods to identify new anti-cancer drug targets and discover first-in-class lead compounds.
The representative works include: development and improvement of allosteric methods based on the induced fit of conformation, and precise identification of anti-cancer drug targets from clinical samples; discovery of phd thesis protease purification allosteric modulators for undruggable targets using our developed allosteric methods. He has published more than papers in Nature, phd thesis protease purification, Nat Chem Biol, etc.
Moreover, the developed allosteric methods from Prof. Zhang have been accessed by more than 60, users over countries.
Choose the best format for your PhD thesis
, time: 10:12Theses and Dissertations Available from ProQuest | Theses and Dissertations | Purdue University
PhD thesis, Universiti Sains Malaysia. Al-Wasabi, Ola Ahmed Mohammed () Flash Cache Hybrid Storage System For Video-On-Demand Server. PhD thesis, Universiti Sains Malaysia. Kuldas, Seffetullah () An Academic Resilience Scale And Model For Malaysian Adolescents. PhD thesis, Universiti Sains Malaysia Thesis Title: The Mechanism of Carcinogenesis by Urethane. S L Kitson. 'New applications of the protecting group di-(4-methoxyphenyl)methyl: N-protection of urethanes and uridines, and efficient removal by either ceric ammonium nitrate/silica or 2,3-dichloro-5,6-dicyanoquinone', Tetrahedron Letts; , 33, Leroy "Lee" Edward Hood (born October 10, ) is an American biologist who has served on the faculties at the California Institute of Technology (Caltech) and the University of Washington. Hood has developed ground-breaking scientific instruments which made possible major advances in the biological sciences and the medical sciences. These include the first gas phase protein sequencer (
No comments:
Post a Comment